Sequegenics, founded with a mission to revolutionize genetic analysis, offers a fully automated cloud platform specializing in long-read next-generation sequencing (NGS) services. The company's core vision is to provide researchers and clinicians with comprehensive tools for detecting structural variants and other complex genetic variations. Their proprietary algorithms and pipelines streamline the process, enabling an in-depth understanding of genetic underpinnings of diseases. Sequegenics primarily focuses on serving the needs of the biomedical research and clinical diagnostics markets.

Notable figures affiliated with Sequegenics include leading geneticists and bioinformatics experts who contribute to the platform's development and innovation. The company has attracted investment from prominent venture capital firms specializing in biotech and health tech sectors. Key achievements include the successful deployment of their platform in various research institutions and clinical settings, significantly advancing the detection and analysis of complex genetic variants. Sequegenics' impact lies in its ability to provide personalized support and cutting-edge solutions, empowering users to gain unique insights into genetic diseases.